Paper35791104
Mucopolysaccharidosis: A broad review.
Nagpal R and 6 others. Indian J Ophthalmol, 2022. Cited by 56 papers, by iCite.
Cite this record
ConductScience Library. Mucopolysaccharidosis: A broad review. Papers, record 35791104. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35791104
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Corneal Diseases | Major topic |
| Corneal Opacity | Major topic |
| Corneal Transplantation | Major topic |
| Mucopolysaccharidoses | Major topic |
| Humans | |
| Quality of Life |
Source PubMed
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11668611 | Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications. | Hum Mutat | 2001 | https://conductscience.org/library/papers/11668611 | PubMed |
| 2 | 25103575 | Early treatment is associated with improved cognition in Hurler syndrome. | Ann Neurol | 2014 | https://conductscience.org/library/papers/25103575 | PubMed |
| 3 | 3085183 | Uveal effusion in Hunter's syndrome. Evidence that abnormal sclera is responsible for the uveal effusion syndrome. | Retina | 1986 | https://conductscience.org/library/papers/3085183 | PubMed |
| 4 | 21305347 | Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses. | Metab Brain Dis | 2011 | https://conductscience.org/library/papers/21305347 | PubMed |
| 5 | 11592832 | Adenovirus-mediated gene therapy for corneal clouding in mice with mucopolysaccharidosis type VII. | Mol Ther | 2001 | https://conductscience.org/library/papers/11592832 | PubMed |
| 6 | 20852315 | Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis. | Br J Ophthalmol | 2011 | https://conductscience.org/library/papers/20852315 | PubMed |
| 7 | 22394489 | Use of iris recognition camera technology for the quantification of corneal opacification in mucopolysaccharidoses. | Br J Ophthalmol | 2012 | https://conductscience.org/library/papers/22394489 | PubMed |
| 8 | 17923542 | Ocular changes in patients with mucopolysaccharidosis I receiving enzyme replacement therapy: a 4-year experience. | Arch Ophthalmol | 2007 | https://conductscience.org/library/papers/17923542 | PubMed |
| 9 | 20553232 | Ocular axial length and corneal refraction in children with mucopolysaccharidosis (MPS I-Hurler). | Acta Ophthalmol | 2012 | https://conductscience.org/library/papers/20553232 | PubMed |
| 10 | 11405343 | Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties. | J Inherit Metab Dis | 2001 | https://conductscience.org/library/papers/11405343 | PubMed |
| 11 | 17464575 | Negative ERGs in mucopolysaccharidoses (MPS) Hurler-Scheie (I-H/S) and Hurler (I-H)-syndromes. | Doc Ophthalmol | 2007 | https://conductscience.org/library/papers/17464575 | PubMed |
| 12 | 31246979 | Corneal topometric, aberrometric and biomechanical parameters in mucopolysaccharidosis patients. | PLoS One | 2019 | https://conductscience.org/library/papers/31246979 | PubMed |
| 13 | 19117887 | Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I. | Pediatrics | 2009 | https://conductscience.org/library/papers/19117887 | PubMed |
| 14 | 25624320 | Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study. | Blood | 2015 | https://conductscience.org/library/papers/25624320 | PubMed |
| 15 | 33747789 | Clinical and genetic features of 13 patients with mucopolysaccarhidosis type IIIB: Description of two novel NAGLU gene mutations. | Mol Genet Metab Rep | 2021 | https://conductscience.org/library/papers/33747789 | PubMed |
| 16 | 22136369 | Clinical guidelines for diagnosing and managing ocular manifestations in children with mucopolysaccharidosis. | Acta Ophthalmol | 2012 | https://conductscience.org/library/papers/22136369 | PubMed |
| 17 | 821556 | Ocular manifestations and pathology of systemic mucopolysaccharidoses. | Birth Defects Orig Artic Ser | 1976 | https://conductscience.org/library/papers/821556 | PubMed |
| 18 | 8114478 | [Clearing of the para-transplant host cornea after perforating keratoplasty in Maroteaux-Lamy syndrome (type VI-A mucopolysaccharidosis)]. | Klin Monbl Augenheilkd | 1993 | https://conductscience.org/library/papers/8114478 | PubMed |
| 19 | 20663562 | Indications and outcomes of deep anterior lamellar keratoplasty in children. | Ophthalmology | 2010 | https://conductscience.org/library/papers/20663562 | PubMed |
| 20 | 16857766 | Inhibition of glycosaminoglycan synthesis using rhodamine B in a mouse model of mucopolysaccharidosis type IIIA. | Pediatr Res | 2006 | https://conductscience.org/library/papers/16857766 | PubMed |
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42859275 | Inhibition of heparan sulfate synthesis by resveratrol in mucopolysaccharidosis type I and IIIB. | Metab Brain Dis | 2026 | https://conductscience.org/library/papers/42859275 | PubMed |
| 42782417 | Characterization of Cellular Alterations in a Novel NAGLU Enzyme-Deficient Cellular Model Generated from U-87MG Cell Line. | Neurochem Res | 2026 | https://conductscience.org/library/papers/42782417 | PubMed |
| 42762012 | A Rare Septuagenarian Patient with a Mild Form of Mucopolysaccharidosis Type IIIC with Ocular Manifestations: A Case Report. | Case Rep Ophthalmol | 2026 | https://conductscience.org/library/papers/42762012 | PubMed |
| 42528835 | Clinical and Radiological Features Suggestive of Mucopolysaccharidosis in Two Siblings From Sudan: A Case Series. | Clin Case Rep | 2026 | https://conductscience.org/library/papers/42528835 | PubMed |
| 42510912 | Advances in Therapies for Mucopolysaccharidoses. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42510912 | PubMed |
| 42467880 | Guidelines for home-based enzyme replacement therapy in children and adolescents with mucopolysaccharidosis: a scoping review. | Rev Esc Enferm USP | 2026 | https://conductscience.org/library/papers/42467880 | PubMed |
| 42400019 | Patient-driven surveys of mucopolysaccharidoses revealed patient-reported outcomes in the Japan MPS patient and family group. | Orphanet J Rare Dis | 2026 | https://conductscience.org/library/papers/42400019 | PubMed |
| 42081553 | Dental Health in Pediatric Patients With Different Types of Mucopolysaccharidosis: Retrospective Cross-Sectional Study. | JMIR Pediatr Parent | 2026 | https://conductscience.org/library/papers/42081553 | PubMed |
| 42033570 | A novel IDS variant associated with an isolated ocular phenotype in Hunter syndrome. | Doc Ophthalmol | 2026 | https://conductscience.org/library/papers/42033570 | PubMed |
| 41814247 | Mucopolysaccharidosis II with diverse genetic origins in a single family: a case series and literature review. | BMC Pediatr | 2026 | https://conductscience.org/library/papers/41814247 | PubMed |
| 41783940 | Development and characterization of a model of mucopolysaccharidosis type IVA for evaluating therapies targeting bone disease. | Dis Model Mech | 2026 | https://conductscience.org/library/papers/41783940 | PubMed |
| 41750382 | Evaluation of GlcNAc-Configured Glycomimetics as Pharmacological Chaperones of NAGLU for the Treatment of Mucopolysaccharidosis IIIB. | Biomolecules | 2026 | https://conductscience.org/library/papers/41750382 | PubMed |
| 41310305 | The use of genistein and ambroxol may be an effective approach in correcting cellular dysfunctions of mucopolysaccharidosis-plus syndrome. | Mamm Genome | 2025 | https://conductscience.org/library/papers/41310305 | PubMed |
| 41302632 | Guidance for Home Enzyme Replacement Therapy in Children and Adolescents Diagnosed with Mucopolysaccharidoses: A Scoping Review Protocol. | Int J Environ Res Public Health | 2025 | https://conductscience.org/library/papers/41302632 | PubMed |
| 41154677 | Mucopolysaccharidoses-What Clinicians Need to Know: A Clinical, Biochemical, and Molecular Overview. | Biomolecules | 2025 | https://conductscience.org/library/papers/41154677 | PubMed |
| 41029071 | A case report on the treatment of autoimmune hemolytic anemia after CBT by daratumumab in a mucopolysaccharidosis type III patient. | Medicine (Baltimore) | 2025 | https://conductscience.org/library/papers/41029071 | PubMed |
| 40830667 | Efficacy and safety of a biosimilar laronidase versus the reference laronidase in patients with mucopolysaccharidosis type I. | Sci Rep | 2025 | https://conductscience.org/library/papers/40830667 | PubMed |
| 40771184 | Exploring Molecular and Phenotypic Characteristics of NAGLU Arg234Gly and Asp312Asn Variants. | Mol Syndromol | 2025 | https://conductscience.org/library/papers/40771184 | PubMed |
| 40758165 | Cellular and molecular changes in mucopolysaccharidosis-plus syndrome caused by a homozygous c.599G > C (p.Arg200Pro) variant of the VPS33A gene. | J Appl Genet | 2026 | https://conductscience.org/library/papers/40758165 | PubMed |
| 40704327 | Iron metabolism and hematological abnormalities in adult patients affected with mucopolysaccharidoses. | Mol Genet Metab Rep | 2025 | https://conductscience.org/library/papers/40704327 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ARSB | 411 | PubTator's text mining | https://conductscience.org/library/genes/411 | NCBI Gene |
| EGF | 1950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| GALNS | 2588 | PubTator's text mining | https://conductscience.org/library/genes/2588 | NCBI Gene |
| GLB1 | 2720 | PubTator's text mining | https://conductscience.org/library/genes/2720 | NCBI Gene |
| GNS | 2799 | PubTator's text mining | https://conductscience.org/library/genes/2799 | NCBI Gene |
| GUSB | 2990 | PubTator's text mining | https://conductscience.org/library/genes/2990 | NCBI Gene |
| HYAL1 | 3373 | PubTator's text mining | https://conductscience.org/library/genes/3373 | NCBI Gene |
| IDS | 3423 | PubTator's text mining | https://conductscience.org/library/genes/3423 | NCBI Gene |
| IDUA | 3425 | PubTator's text mining | https://conductscience.org/library/genes/3425 | NCBI Gene |
| NAGLU | 4669 | PubTator's text mining | https://conductscience.org/library/genes/4669 | NCBI Gene |
| SGSH | 6448 | PubTator's text mining | https://conductscience.org/library/genes/6448 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35791104
GET https://conductscience.org/api/papers/v1/35791104/references?page=2